Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hedrich

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 20, 2011
ECDC and EMCDDA joint guidance report on reducing infections among people who inject drugsM Salminen, D Hedrich
Pharmaceutical Research|February 23, 2021
Friend or Foe: Xenobiotic Activation of Nrf2 in Disease Control and CardioprotectionWilliam D Hedrich, Hongbing Wang
Gastroenterology|June 1, 1993
Upper gastrointestinal bleeding in the critically illR G Karlstadt, D Hedrich, R Palmer
Acta Pharmaceutica Sinica. B|October 7, 2016
Insights into CYP2B6-mediated drug-drug interactionsWilliam D Hedrich, Hazem E Hassan, Hongbing Wang
Archiv Fur Gynakologie|September 28, 1973
[Proceedings: Blood group incompatibility and fertility]H Krieg, A G Gathof, P Netter, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 24, 2009
Rebound of overdose mortality in the European Union 2003-2005: findings from the 2008 EMCDDA Annual ReportJ Vicente, Isabelle Giraudon, J Matias, et al.
Drug and Alcohol Review|July 10, 2003
Drug consumption facilities: an update since 2000J Kimber, K Dolan, I van Beek, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 13, 2010
Injecting drug use in Europe: stable or decliningL Wiessing, D Klempová, D Hedrich, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2009
Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritisK G Naber, L Llorens, K Kaniga, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 26, 2009
Drug use and pregnancy - challenges for public healthV A Gyarmathy, I Giraudon, D Hedrich, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 20, 2011
ECDC and EMCDDA joint guidance report on reducing infections among people who inject drugsM Salminen, D Hedrich
Pharmaceutical Research|February 23, 2021
Friend or Foe: Xenobiotic Activation of Nrf2 in Disease Control and CardioprotectionWilliam D Hedrich, Hongbing Wang
Gastroenterology|June 1, 1993
Upper gastrointestinal bleeding in the critically illR G Karlstadt, D Hedrich, R Palmer
Acta Pharmaceutica Sinica. B|October 7, 2016
Insights into CYP2B6-mediated drug-drug interactionsWilliam D Hedrich, Hazem E Hassan, Hongbing Wang
Archiv Fur Gynakologie|September 28, 1973
[Proceedings: Blood group incompatibility and fertility]H Krieg, A G Gathof, P Netter, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 24, 2009
Rebound of overdose mortality in the European Union 2003-2005: findings from the 2008 EMCDDA Annual ReportJ Vicente, Isabelle Giraudon, J Matias, et al.
Drug and Alcohol Review|July 10, 2003
Drug consumption facilities: an update since 2000J Kimber, K Dolan, I van Beek, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 13, 2010
Injecting drug use in Europe: stable or decliningL Wiessing, D Klempová, D Hedrich, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2009
Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritisK G Naber, L Llorens, K Kaniga, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 26, 2009
Drug use and pregnancy - challenges for public healthV A Gyarmathy, I Giraudon, D Hedrich, et al.
Pageof 3